Opioids News and Research

RSS
An opioid is a chemical that works by binding to opioid receptors, which are found principally in the central nervous system and the gastrointestinal tract. The receptors in these two organ systems mediate both the beneficial effects and the side effects of opioids.
YM Biosciences to present JAK1/2 inhibiting small molecule and vascular disrupting agent data at Cancer Conference

YM Biosciences to present JAK1/2 inhibiting small molecule and vascular disrupting agent data at Cancer Conference

QRxPharma announces the initiation of second pivotal Phase 3 registration trial of MoxDuo IR

QRxPharma announces the initiation of second pivotal Phase 3 registration trial of MoxDuo IR

YM BioSciences receives additional AeroLEF patents in U.S.

YM BioSciences receives additional AeroLEF patents in U.S.

Doctors do not follow evidence-based guidelines for treating low back pain, says report

Doctors do not follow evidence-based guidelines for treating low back pain, says report

Positive data from Cara Therapeutics' peripherally-restricted kappa opioid agonist Phase II trial

Positive data from Cara Therapeutics' peripherally-restricted kappa opioid agonist Phase II trial

'Doctor Shopping': Data from California's prescription monitoring program

'Doctor Shopping': Data from California's prescription monitoring program

"Knowledge deficit" about methadone responsible for resulting deaths

"Knowledge deficit" about methadone responsible for resulting deaths

Javelin Pharmaceuticals' NDA for Dyloject Injection accepted for formal review

Javelin Pharmaceuticals' NDA for Dyloject Injection accepted for formal review

Positive results from Phosphagenics' TPM Phase 1B clinical study for transdermal delivery of oxycodone

Positive results from Phosphagenics' TPM Phase 1B clinical study for transdermal delivery of oxycodone

YM BioSciences-Cytopia merger complete

YM BioSciences-Cytopia merger complete

NIDA supports Omeros' Addiction program

NIDA supports Omeros' Addiction program

YM BioSciences' nimotuzumab Phase II trials: FDA advises patient enrollment

YM BioSciences' nimotuzumab Phase II trials: FDA advises patient enrollment

Taking opioids long term could hold small risk of addition

Taking opioids long term could hold small risk of addition

Light sedation decreases postoperative delirium in elderly patients by 50%

Light sedation decreases postoperative delirium in elderly patients by 50%

DURECT commences dosing in its POSIDUR Phase III clinical trial

DURECT commences dosing in its POSIDUR Phase III clinical trial

New issue from Annals of Internal Medicine

New issue from Annals of Internal Medicine

Lighter sedation during spinal anesthesia reduces postoperative delirium in elderly patients

Lighter sedation during spinal anesthesia reduces postoperative delirium in elderly patients

Study examines how opioid overdose differs by prescribed dose for chronic pain conditions

Study examines how opioid overdose differs by prescribed dose for chronic pain conditions

Risks associated with opioid pain medications may outweigh surgery risks

Risks associated with opioid pain medications may outweigh surgery risks

YM BioSciences announces results of cancer antibody-radionuclide conjugate development collaboration

YM BioSciences announces results of cancer antibody-radionuclide conjugate development collaboration

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.